Less Ads, More Data, More Tools Register for FREE

Pin to quick picksArgentex Group. Regulatory News (AGFX)

  • This share is currently suspended. It was suspended at a price of 2.45
  • There is currently no data for AGFX

Form 8.5 (EPT/RI)

6 Jun 2025 10:21

RNS Number : 8146L
Singer Capital Markets Sec Ltd
06 June 2025
 

 FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Singer Capital Markets Securities Ltd

 

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Argentex Group PLC

 

(c) Name of the party to the offer with which exempt principal trader is connected:

Argentex Group PLC

 

(d) Date dealing undertaken:

05 June 2025

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

NO

If YES, specify which:

 

 

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

 

ORD 0.01P

 

Purchases

 

411,716

 

2.4335p

 

2.4341p

 

ORD 0.01P

 

Sales

 

310,209

 

2.454p

 

2.4649p

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

 

Date of disclosure:

06 June 2025

Contact name:

Cindy Le

Telephone number:

020 7496 3171

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service. 

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERUNUKRVRUNRRR
Date   Source Headline
23rd Apr 202510:30 amRNSStatement regarding Argentex Group plc
23rd Apr 20259:48 amRNSForm 8.3 - Argentex Group plc
23rd Apr 20257:00 amRNSHolding(s) in Company
23rd Apr 20257:00 amRNSResponse to Media Speculation & Financial Position
22nd Apr 20257:40 amRNSSuspension - Argentex Group Plc
22nd Apr 20257:15 amRNSFinancial Position & Suspension of trading
15th Apr 202510:30 amRNSPublication of Annual Report and Notice of AGM
11th Apr 20254:35 pmRNSDirector/PDMR Shareholding
7th Apr 202510:21 amRNSDirector/PDMR Shareholding
4th Apr 20259:31 amRNS-RNotice of Investor Presentation
3rd Apr 20253:51 pmRNSDirector/PDMR Shareholding
2nd Apr 20254:33 pmRNSResults of GM, Grant of Awards, PDMR Notifications
2nd Apr 202512:55 pmRNSAppointment of Non-Executive Director
2nd Apr 20257:00 amRNSFinal Results
19th Mar 20257:00 amRNSNotice of Full Year Results
17th Mar 20253:00 pmRNSShareholder Circular & Notice of General Meeting
21st Jan 20257:00 amRNSTrading Update
4th Dec 202412:00 pmRNSDirector/PDMR Shareholding
9th Oct 20244:00 pmRNSCancellation of Long-Term Incentive Plan
3rd Oct 20243:00 pmRNSDirector / PDMR Dealing
1st Oct 202411:00 amRNSDirector / PDMR Dealing
18th Sep 20247:01 amRNSAppointment of Non-Executive Director
18th Sep 20247:00 amRNSInterim results for the six months to 30 June 2024
14th Aug 20247:00 amRNSNotice of Interim Results & Investor Presentation
9th Jul 20247:00 amRNSHalf year trading update
19th Jun 20245:34 pmRNSResult of AGM
6th Jun 20247:00 amRNSInvestor Presentation of FY 2023 Results
4th Jun 20247:00 amRNSAGFX secures Australian Financial Services License
17th May 20243:30 pmRNSHolding(s) in Company
13th May 20246:20 pmRNSDirector/PDMR Dealings
13th May 20241:45 pmRNSPublication of Annual Report and Notice of AGM
9th May 20246:00 pmRNSResult of Placing and Retail Offer
9th May 202410:40 amRNSDirector / PDMR Dealing
3rd May 20247:00 amRNSRetail Offer
2nd May 20245:55 pmRNSResults of Placing
2nd May 20247:01 amRNSProposed Fundraise
2nd May 20247:00 amRNSFull Year Results For the Year Ended 31/12/2023
17th Apr 20247:00 amRNSHolding(s) in Company
27th Feb 20247:00 amRNSHolding(s) in Company
23rd Feb 20247:00 amRNSHolding(s) in Company
14th Feb 20247:00 amRNSHolding(s) in Company
1st Feb 20247:00 amRNSHolding(s) in Company
30th Jan 20247:00 amRNSTrading Update and CFO appointment
23rd Nov 20237:00 amRNSDirector/PDMR Dealing
21st Nov 20234:12 pmRNSDirector/PDMR Dealing
16th Nov 20239:23 amRNSAppointment of Non-executive Director
10th Nov 20237:00 amRNSTrading Statement
9th Nov 20233:18 pmRNSStandard form for notification of major holdings
9th Nov 20237:00 amRNSBoard Change
6th Nov 20239:35 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.